93000-03-4
93000-03-4 structure
- Name: Boc-DL-Met-OH
- Chemical Name: 2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoic acid
- CAS Number: 93000-03-4
- Molecular Formula: C10H19NO4S
- Molecular Weight: 249.327
- Catalog: Biochemical Amino acids and their derivatives Methionine derivatives
- Create Date: 2018-12-13 15:13:20
- Modify Date: 2026-07-03 18:02:34
-
(tert-Butoxycarbonyl)methionine is a Methionine (HY-13694) derivative[1].
| Name | 2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoic acid |
|---|---|
| Synonyms |
(tert-Butoxycbonyl)methionine
2-[(2-methylpropan-2-yl)oxycbonylamino]-4-methylsulfanylbutanoicaci BOC-DL-MET-OH N-(tert-butoxycarbonyl)methionine Boc-methionine Boc-Dl-Met-Oh N-tert-Butoxycbonyl-DL-methionine 2-(R,S)-2-[(tert-butoxycarbonyl)amino]-4-(methylsulfanyl)butanoic acid EINECS 219-639-3 N-(t-butoxycarbonyl)-methionine N-(tert-Butoxycarbonyl)-methionine 2-{[(tert-butoxy)carbonyl]amino}-4-(methylsulfanyl)butanoic acid BOC-DL-METHIONINE N-Boc-DL-Methionine BOC-DL-MET-OH //BP BOC-DL-Methionine N-{[(2-Methyl-2-propanyl)oxy]carbonyl}methionine t-butoxycarbonylmethionine Methionine, N-[(1,1-dimethylethoxy)carbonyl] 2R-tert-Butoxycarbonylamino4-methylsulfanyl-butyric acid N-T-BUTOXYCBONYL-DL-METHIONINE L-Methionine,N-[(1,1-dimethylethoxy)carbonyl] N-tBoc-DL-methionine Boc-DL-Met N-[(1,1-Dimethylethoxy)carbonyl]-Methionine |
| Description | (tert-Butoxycarbonyl)methionine is a Methionine (HY-13694) derivative[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 415.5±40.0 °C at 760 mmHg |
| Molecular Formula | C10H19NO4S |
| Molecular Weight | 249.327 |
| Flash Point | 205.1±27.3 °C |
| Exact Mass | 249.103485 |
| PSA | 100.93000 |
| LogP | 2.15 |
| Appearance | Solid |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.500 |
| Storage condition | Store at RT. |
|
~84%
93000-03-4 |
| Literature: Picha, Jan; Vanek, Vaclav; Budesinsky, Milos; Mladkova, Jana; Garrow, Timothy A.; Jiracek, Jiri European Journal of Medicinal Chemistry, 2013 , vol. 65, p. 256 - 275 |
|
~98%
93000-03-4 |
| Literature: Hioki, Kazuhito; Kinugasa, Mizuho; Kishimoto, Michiko; Fujiwara, Miho; Tani, Shohei; Kunishima, Munetaka Synthesis, 2006 , # 12 p. 1931 - 1933 |
|
~%
93000-03-4 |
| Literature: Glaxo Wellcome Inc. Patent: US5994344 A1, 1999 ; |
|
~85%
93000-03-4 |
| Literature: Kim, Sunggak; Chang, Heung Journal of the Chemical Society, Chemical Communications, 1983 , # 22 p. 1357 - 1358 |
|
~%
93000-03-4 |
| Literature: McKay; Albertson Journal of the American Chemical Society, 1957 , vol. 79, p. 4686,4689 |
|
~%
93000-03-4 |
| Literature: Anderson; McGregor Journal of the American Chemical Society, 1957 , vol. 79, p. 6180,6181 |
| Precursor 7 | |
|---|---|
| DownStream 2 | |
